Alvotech (ALVO) Stock Price

5.19 ▲ +0.24 (+4.85%)
Open: 5.045 Vol: 30.06K Day's range: 5.045 - 5.265 Aug 31, 15:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ALVO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 5.21▼ 5.20▼ 5.19▲ 5.00▲ 4.49▲
MA10 5.21▼ 5.19▼ 5.11▲ 4.69▲ 4.00▲
MA20 5.20▼ 5.09▲ 4.99▲ 4.29▲ 3.77▲
MA50 5.19▼ 4.98▲ 4.94▲ 3.80▲ 4.72▲
MA100 5.13▲ 4.89▲ 4.46▲ 3.68▲ 7.66▼
MA200 5.00▲ 4.41▲ 4.01▲ 4.15▲ 9.44▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.001▼ 0.005▲ 0.021▲ 0.092▲ 0.278▲
RSI 45.408▼ 62.375▲ 65.116▲ 71.898▲ 61.839▲
STOCH 74.603     67.370     81.717▲ 79.094     76.952    
WILL %R -66.667     -23.077▲ -17.857▲ -12.195▲ -8.163▲
CCI -173.118▼ 42.393     71.240     98.062     194.326▲
Latest Filters Detected On ALVO
BBANDS $ALVO Bollinger Bands Expanding Set Alert
▲ RSI $ALVO RSI(14) Crossed Above 70 Set Alert
Alvotech News
Alvotech S.A.: Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio to subcutaneous ...
Monday, August 31, 2026 02:29 AM
REYKJAVIK, Iceland, August 31, 2026 - Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, ...
Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations
Monday, August 31, 2026 01:29 AM
Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and ...
Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations
Monday, August 31, 2026 01:29 AM
Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and ...
ALVO historical stock data
date open high low close volume
31/08/26 5.04 5.265 5.04 5.19 1,123,623
28/08/26 4.835 5.00 4.82 4.95 875,325
27/08/26 4.90 4.9792 4.785 4.88 967,679
26/08/26 4.98 4.99 4.782 4.91 889,919
25/08/26 5.225 5.39 5.015 5.05 1,771,686
24/08/26 4.83 5.35 4.715 5.265 3,110,368
21/08/26 4.32 4.59 4.32 4.43 2,267,736
20/08/26 3.89 4.37 3.75 4.27 1,370,334
19/08/26 4.00 4.08 3.94 3.99 513,592
18/08/26 3.92 4.00 3.83 3.95 675,393
Quote Details
52wk Low:2.94
52wk High:9.25
Vol:30.06K
Avg Vol(3m):21M
1Y Chng:-34.55%
1M Chng:+47.44%
Add to Watch List
More Information
Index US Composite
Market Cap. 1.74B